KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression.
KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression.
复制标题
DOI:
10.1172/jci.insight.165002
复制
发表时间:
2023-04-10
期刊:
影响因子:
8
通讯作者:
Campbell, Kirk N.
中科院分区:
文献类型:
--
作者:
Meliambro, Kristin;Yang, Yanfeng;de Cos, Marina;Ballestas, Estefania Rodriguez;Malkin, Caroline;Haydak, Jonathan;Lee, John R.;Salem, Fadi;Mariani, Laura H.;Gordon, Ronald E.;Basgen, John M.;Wen, Huei Hsun;Fu, Jia;Azeloglu, Evren U.;He, John Cijiang;Wong, Jenny S.;Campbell, Kirk N.
Despite recent progress in the identification of mediators of podocyte injury, mechanisms underlying podocyte loss remain poorly understood, and cell-specific therapy is lacking. We previously reported that kidney and brain expressed protein (KIBRA), encoded by WWC1, promotes podocyte injury in vitro through activation of the Hippo signaling pathway. KIBRA expression is increased in the glomeruli of patients with focal segmental glomerulosclerosis, and KIBRA depletion in vivo is protective against acute podocyte injury. Here, we tested the consequences of transgenic podocyte-specific WWC1 expression in immortalized human podocytes and in mice, and we explored the association between glomerular WWC1 expression and glomerular disease progression. We found that KIBRA overexpression in immortalized human podocytes promoted cytoplasmic localization of Yes-associated protein (YAP), induced actin cytoskeletal reorganization, and altered focal adhesion expression and morphology. WWC1-transgenic (KIBRA-overexpressing) mice were more susceptible to acute and chronic glomerular injury, with evidence of YAP inhibition in vivo. Of clinical relevance, glomerular WWC1 expression negatively correlated with renal survival among patients with primary glomerular diseases. These findings highlight the importance of KIBRA/YAP signaling to the regulation of podocyte structural integrity and identify KIBRA-mediated injury as a potential target for podocyte-specific therapy in glomerular disease.
登录
查看更多内容
影响因子:
4.8
作者:
Meliambro, Kristin;Wong, Jenny S.;Campbell, Kirk N.
通讯作者:
Campbell, Kirk N.
影响因子:
9.8
作者:
Rosse C;Formstecher E;Boeckeler K;Zhao Y;Kremerskothen J;White MD;Camonis JH;Parker PJ
通讯作者:
Parker PJ
影响因子:
11.8
作者:
Genevet A;Wehr MC;Brain R;Thompson BJ;Tapon N
通讯作者:
Tapon N
影响因子:
8.8
作者:
Liu X;Li H;Rajurkar M;Li Q;Cotton JL;Ou J;Zhu LJ;Goel HL;Mercurio AM;Park JS;Davis RJ;Mao J
通讯作者:
Mao J
影响因子:
19.6
作者:
Reiser, Jochen;Gupta, Vineet;Kistler, Andreas D.
通讯作者:
Kistler, Andreas D.